622 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
GM's Latest Has Sensors and Room for 6, but No Steering Wheel https://www.wired.com/story/gms-sensors-room-6-no-steering-wheel/ Jan 21, 2020 - Cruise reveals the Origin, its planned self-driving vehicle, meant to be shared by riders in a ride-hail service.
Essex Property Trust: Still Has Potential https://seekingalpha.com/article/4655938-essex-property-trust-still-potential-maintain-buy?source=feed_all_articles Dec 04, 2023 - Essex Property Trust has a strong balance sheet, a history of increasing dividends, and a relatively low valuation vs. historical averages. Read more on ESS here.
Oil Demand Has Fallen, But It's Not All Doom And Gloom https://seekingalpha.com/article/4656481-oil-demand-fallen-its-not-all-doom-gloom?source=feed_all_articles Dec 06, 2023 - For all the talk of recession, oil demand has held up relatively well.
This Overlooked Stock Is Up 392% Since 2018 and Has Plenty of Growth Left https://www.fool.com/investing/2023/12/07/overlook-stock-up-392-2018-growth-goosehead/?source=iedfolrf0000001 Dec 07, 2023 - Here's one stock no one is talking about that can help you build long-term wealth.
This Stock Has Surged 53% Since Black Friday. Here's Why I'm Not Buying It Quite Yet. https://www.fool.com/investing/2023/12/08/stock-surged-53-since-black-friday-not-buy-affirm/?source=iedfolrf0000001 Dec 08, 2023 - This company stands to benefit from the surge in buy now, pay later usage during the holiday shopping week.
Forget Nerdy Stock -- This Learning Company Has Far More Potential https://www.fool.com/investing/2023/12/08/forget-nerdy-stock-this-learning-company-has-far-m/?source=iedfolrf0000001 Dec 08, 2023 - Duolingo generates superior growth from a simpler business model.
bluebird bio gene therapy lovo-cel for sickle cell disease has $3.1M cost (updated) https://seekingalpha.com/news/4044803-bluebird-bio-gains-fda-approval-gene-therapy-lovo-cell-sickle-cell-disease?source=feed_sector_healthcare Dec 08, 2023 - The FDA approves bluebird bio's gene therapy for sickle cell disease, boosting shares by 7%. Read more here.
This Top Stock Has Tripled Since 2020, and It Looks Like a Bargain. Time to Buy? https://www.fool.com/investing/2023/12/09/this-top-stock-has-tripled-since-2020-and-it-looks/?source=iedfolrf0000001 Dec 09, 2023 - This jewelry stock just hit a 52-week high, but it still looks undervalued.
Gold Rally Has Just Started https://seekingalpha.com/article/4657034-gold-rally-has-just-started?source=feed_all_articles Dec 09, 2023 - Gold prices rallied and are near 10-year highs, with potential for further gains. Read what leads to a weakening dollar and potential gold price appreciation.
'Somebody has it wrong' on U.S. recession risks as oil, gold and Treasurys diverge, fund manager says https://www.cnbc.com/2023/12/11/oil-gold-and-treasurys-diverge-on-us-recession-risk-livermores-neuhauser.html Dec 11, 2023 - Falling oil prices and rising gold prices indicate growing recessionary fears — but 10-year Treasury yields jumped Friday amid hopes of a soft landing.

Pages: 123456...63

Page 1>